The purpose of the study was based on the analysis of calculated biochemical parameters of mineralization in the blood serum of laboratory rats to evaluate the course of metabolic processes in bone tissue after filling a defect of critical size in the metaphysis of the femur with allogeneic bone implants saturated with mesenchymal stem cells. Materials and methods. Indicators of mineralization of bone tissue in the blood serum of white rats were studied (the content of total protein, calcium, alkaline and acid phosphatase activity), the ratio of alkaline to acid phosphatase activity, as well as the degree of mineralization, were calculated. Results and discussion. In 3-month-old rats with alloimplants without mesenchymal stem cells on the 90th day, a decrease in the degree of mineralization was observed, which reflects the final stages of bone tissue remodeling by 1.13 times compared to the level of this in animals of a similar age and conditions of filling the defect on the 14th day (р = 0.008) and 1.12 times compared to the data on the 28th day of the experiment (р = 0.008). In 3-month-old rats with alloimplants saturated with mesenchymal stem cells, a decrease in the degree of mineralization on the 90th day was determined compared to that in experimental rats of a similar age and defect filling conditions on the 14th day by 1.13 times (p = 0.008), and compared with the data of the similar group on the 28th day – 1.14 times (p = 0.008), which reflects the delay in the course of the full stage of bone tissue remodeling due to the use of mesenchymal stem cells. The ratio of serum alkaline to acid phosphatase activity in 3-month-old rats with alloimplants saturated with mesenchymal stem cells was 1.32 times lower on the 14th day compared to the data of a group of the same age with alloimplants without mesenchymal stem cells (p = 0.008), and on the 90th day – by 1.12 times (p = 0.008), which also indicates a delay in the early stages of bone tissue mineralization due to the use of mesenchymal stem cells as part of alloimplants. In 12-month-old rats without the use of mesenchymal stem cells, on the 90th day, there was a decrease in the degree of mineralization by 1.10 times, in accordance with the level of this in a group of rats of a similar age and conditions of defect filling on the 14th day (р = 0.008) and by 1.09 times compared to that on the 28th day (p = 0.008), from which we can conclude about a progressive decrease in the activity of the final stages of bone tissue remodeling. The ratio of the activity of alkaline and acid phosphatase in 12-month-old rats with alloimplants without mesenchymal stem cells on the 90th day was significantly inferior to that in the corresponding 3-month-old animals by 1.12 times (p = 0.008), which indicates a lower activity of the initial stages of bone tissue mineralization in the late stages of defect healing. This indicator progressively decreased during the experiment. Thus, on the 28th day, it was 1.12 times smaller than on the 14th day, and on the 90th day – by 1.53 times less, in accordance with the data on the 14th day (p = 0.008) and by 1.36 times compared to that on the 28th day (p = 0.008). Conclusion. Treatment of experimental rats with a critical size defect in the femoral metaphysis with alloimplants saturated with mesenchymal stem cells, especially in the early stages, leads to a slowing down of bone tissue remodeling processes

Keywords: alloimplant, defect, modeling, biochemistry, mineralization, calculated indicators

Full text: PDF (Ukr) 290K

1. Hodges WM, O'Brien F, Fulzele S, Hamrick MW. Function of microRNAs in the Osteogenic Differentiation and Therapeutic Application of Adipose-Derived Stem Cells (ASCs). Int J Mol Sci. 2017;18(12):2597. PMID: 29207475. PMCID: PMC5751200. https://doi.org/10.3390/ijms18122597
2. Shafaei H, Kalarestaghi H. Adipose-derived stem cells: An appropriate selection for osteogenic differentiation. J Cell Physiol. 2020 Nov;235(11):8371-8386. PMID: 32239731. https://doi.org/10.1002/jcp.29681
3. Mende W, Götzl R, Kubo Y, Pufe T, Ruhl T, Beier JP. The Role of Adipose Stem Cells in Bone Regeneration and Bone Tissue Engineering. Cells. 2021 Apr 21;10(5):975. PMID: 33919377. PMCID: PMC8143357. https://doi.org/10.3390/cells10050975
4. Reumann MK, Linnemann C, Aspera-Werz RH, Arnold S, Held M, Seeliger C,et al. Donor Site Location Is Critical for Proliferation, Stem Cell Capacity, and Osteogenic Differentiation of Adipose Mesenchymal Stem/Stromal Cells: Implications for Bone Tissue Engineering Int J Mol Sci. 2018 Jun 26;19(7):1868. PMID: 29949865. PMCID: PMC6073876. https://doi.org/10.3390/ijms19071868
5. Xu L, Liu Y, Sun Y, Wang B, Xiong Y, Lin W, et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther. 2017;8(1):275. PMID: 29208029. PMCID: PMC5718061. https://doi.org/10.1186/s13287-017-0716-x
6. Z Y, Li Q, Luo S, Liu Z, Luo D, Zhang B, et al. PPARγ and Wnt Signaling in Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells. Curr Stem Cell Res Ther. 2016;11(3):216-25. PMID: 25986621. https://doi.org/10.2174/1574888x10666150519093429
7. Zhang Z, Yang X, Cao X, Qin A, Zhao J. Current applications of adipose-derived mesenchymal stem cells in bone repair and regeneration: A review of cell experiments, animal models, and clinical trials. Front Bioeng Biotechnol. 2022;10:942128. PMID: 36159705. PMCID: PMC9490047. https://doi.org/10.3389/fbioe.2022.942128
8. Paduano F, Marrelli M, Amantea M, Rengo C, Rengo S, Goldberg M, et al. Adipose Tissue as a Strategic Source of Mesenchymal Stem Cells in Bone Regeneration: A Topical Review on the Most Promising Craniomaxillofacial Applications. Int J Mol Sci. 2017;18(10):2140. PMID: 29027958. PMCID: PMC5666822. https://doi.org/10.3390/ijms18102140
9. Mao S-H, Chen C-H, Chen C-T. Osteogenic potential of induced pluripotent stem cells from human adipose-derived stem cells. Stem Cell Res Ther. 2019;10(1):303. PMID: 31623672. PMCID: PMC6798413. https://doi.org/10.1186/s13287-019-1402-y
10. Verkhovna Rada of Ukraine, Zakon Ukrainy vid 21 lyutoho 2006r. Pro zakhyst tvaryn vid zhorstokoho povodzhennya [On the protection of animals from brutal treatment]. Revision: February 13, 2020, accessed: January 20, 2021 [Ukrainian]. Available from: https://zakon.rada.gov.ua/laws/show/en/3447-15/ed20200213#Text
11. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes Strasbourg, 18.III.1986:11 p. Available from: https://rm.coe.int/168007a67b
12. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes (Text with EEA relevance). Official Journal of the European Union, 2010, 20.10:276/33-276/79. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:en:PDF
13. Poser L, Matthys R, Schawalder P, Pearce S, Alini M, Zeiter S. A standardized critical size defect model in normal and osteoporotic rats to evaluate bone tissue engineered constructs. Biomed Res Int. 2014;2014:348635. PMID: 24738053. https://doi.org/10.1155/2014/348635
14. Tao ZS, Wu XJ, Zhou WS, Wu XJ, Liao W, Yang M, et al. Local administration of aspirin with β–tricalcium phosphate/poly–lactic–co–glycolic acid (β–TCP/PLGA) could enhance osteoporotic bone regeneration. J Bone Miner Metab. 2019;37:1026–35. PMID: 31076895. https://doi.org/10.1007/s00774-019-01008-w
15. Patent 119699 Ukraine, MPK A61K 35/32 (2015.01), A61F 2/28 (2006.01), A61P 19/00. Sposib vyhotovlennya implantatsiynoho dehidratovanoho kistkovoho biomaterialu alohennoho pokhodzhennya [Method of manufacturing implantation dehydrated bone biomaterial of allogeneic origin]. Korzh MO, Vorontsov PM, Slota OM, Husak VS, Vorontsova MP. (UA); zayavniky i vlasniky patentu Korzh MO, Vorontsov PM, Slota OM, Husak VS, Vorontsova MP. (UA). № a201709455 ; zayavl 27.09.2017 ; opubl 25.07.2019. Byul № 14. [Ukrainian]
16. Kamyshnikov VS. Methods of clinical laboratory research. 2018. 736 p. ISBN: 978-5-00030-511-9
17. Lang TA, Sesik МM. How to describe statistics in medicine. An annotated guide for authors, editors, and reviewers. 2011. 480 p. ISBN: 978-5-98811-173-3
18. Talashova IA, Gasanova AG, Тkachuk EА. Demonstration of phosphatase activity and electrolyte exchange under the conditions of implantation of calcium phosphate materials. Genius of Orthopedics. 2010;4:94–98.